Table 4 Serum chemokines, cytokines, and growth/stimulating factors.
From: Immune dysregulation in patients with carpal tunnel syndrome
Marker | Controls | CTS | P-value |
|---|---|---|---|
Chemokines | |||
CCL4 (MIP-1β) | 2.79 (1.60–4.67) | 5.03 (3.74–7.49) | 0.0369 |
CCL5 (RANTES) | 28.89 (25.57–40.38) | 49.28 (44.87–56.25) | 0.000035* |
Eotaxin | 11.46 (5.49–20.76) | 20.07 (11.61–25.70) | 0.1011 |
CXCL10 (IP-10) | 20.53 (13.84–28.54) | 37.76 (31.2–43.11) | 0.0010* |
CCL2 (MCP-1) | 7.83 (1.4–14.2) | 14.78 (11.5–20.26) | 0.0100 |
CXCL8 (IL-8) | 5.33 (4.12–8.91) | 11.37 (7.95–19.72) | 0.0009* |
Cytokines | |||
IL-6 | 1.42 (1.16–1.85) | 1.7 (1.37–2.23) | 0.080 |
IFNγ | 15.2 (11.15–19.37) | 19.84 (12.04–24.07) | 0.113 |
IL-1RA | 33.79 (24.69–49.32) | 37.89 (28.7–49.32) | 1.000 |
IL-5 | 1.07 (0–1.63) | 1.53 (1.16–2) | 0.179 |
TNFα | 0 (0–3.33) | 2.89 (0–3.79) | 0.066 |
IL-2 | 0 (0–0) | 0 (0–0) | 0.788 |
IL-13 | 0 (0–0) | 0 (0–0) | 0.782 |
IL-4 | 0.58 (0.45–0.72) | 0.71 (0.63–0.84) | 0.025 |
IL-10 | 1.82 (1.49–3.22) | 2.91 (1.62–3.86) | 0.372 |
IL-7 | 0 (0–1.57) | 1.64 (0–2.21) | 0.095 |
IL-12 | 1.4 (1.03–1.79) | 2.11 (1.59–3.12) | 0.013 |
IL-17A | 0 (0–1.03) | 1.89 (0–2.93) | 0.005 |
IL-9 | 1.15 (0.76–1.56) | 2.11 (1.56–4.03) | 0.005 |
Growth/Stimulating factors | |||
VEGF | 1.41 (0–2.03) | 5.94 (3.19–7.49) | 0.00025* |
PDGF | 22.18 (14.34–41.14) | 56.60 (35.11–87.77) | 0.00383 |
G-CSF | 13.31 (9.95–19.41) | 18.09 (14.16–21.19) | 0.05107 |
